Cooper City, FLNCT07570862Now EnrollingIRB Ready

Lupus Nephritis Clinical Trial in Cooper City, FL

Access cutting-edge lupus nephritis treatment through this phase 2 clinical trial at a research site in Cooper City. Study-provided care at no cost to qualified participants.

Sponsored by Fate Therapeutics

Quick Self-Assessment

See if you qualify for this Cooper City location

Preparing your pre-screening questions…

Expert Care in Cooper City

Access lupus nephritis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lupus nephritis treatment provided free

Apply for This Cooper City Location

Check if you qualify for this lupus nephritis clinical trial in Cooper City, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cooper City

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cooper City site if eligible
  4. 4Begin participation

About This Lupus Nephritis Study in Cooper City

The primary objective of this trial is to evaluate the efficacy and safety of FT819, comprised of allogeneic T cells that express a CD19-targeted CAR, following bendamustine administration in participants with refractory moderate-to-severe lupus nephritis, as assessed by the proportion of participants who achieve complete renal response (CRR) at Week 26.

Sponsor: Fate Therapeutics

Who Can Participate

Inclusion Criteria

Age ≥12 to ≤70 years
Diagnosis of SLE per EULAR/ACR 2019 classification criteria
Biopsy-proven proliferative Class III or IV LN, with or without concomitant Class V involvement, based on the 2003/2018 ISN/RPS classification
Positivity for at least one of the following autoantibodies at screening:
Antinuclear antibody (ANA)
Anti-double-stranded DNA (anti-dsDNA) or
Anti-Smith antibody
Active disease, defined as: a. Evidence of SLE activity, defined as either: i. SLEDAI-2K ≥6 or ii. At least 1 BILAG A or 2 BILAG B scores for SLE-related organ involvement; and b. Evidence of renal involvement, defined as UPCr ≥1 g/g; and c. Moderate-to-severe renal disease with investigator's impression that improvement is possible
Refractory to ≥2 systemic immunosuppressive therapies for the treatment of LN

Exclusion Criteria

Evidence of inadequate organ function during the screening period
Active central nervous system (CNS) symptoms attributable to autoimmune disease within 12 months prior to trial intervention
History of or current renal diseases (other than LN) that, in the opinion of the investigator, could interfere with assessment of LN or confound evaluation of disease activity
Receipt of dialysis (hemodialysis or peritoneal dialysis) within 12 weeks of trial intervention
Irreversible organ damage related to underlying disease (e.g., ESRD) where, in the opinion of the investigator, CD19 CAR T-cell therapy would be unlikely to benefit the participant
History of malignancy in the prior 5 years
Known allergy to the following FT819 components: albumin (human) or DMSO
History of intolerance or contraindication to bendamustine
Body weight \<30 kg
Any medical condition, clinical laboratory abnormality, or nonmedical/social issue that, per investigator or medical monitor judgement, precludes safe participation in and completion of the trial or that could affect compliance with protocol conduct or interpretation of results

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cooper City?

Yes, this clinical trial (NCT07570862) has an active research site in Cooper City, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lupus Nephritis Treatment Options in Cooper City, FL

If you're searching for lupus nephritis treatment options in Cooper City, FL, this clinical trial (NCT07570862) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cooper City research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced lupus nephritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lupus nephritis clinical trials near you to find additional studies recruiting in your area.

More Lupus Trials in Cooper City, FL

See all lupus clinical trials recruiting in Cooper City — not just this study.

Browse Lupus Trials in Cooper City →

Browse More Trials by Condition

Lupus TrialsPulmonary Hypertension TrialsSystemic Lupus Erythematosus TrialsLupus Nephritis TrialsAll Conditions →

Ready to Join in Cooper City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cooper City, FL